Relationship between obstructive sleep apnea and pulmonary hypertension: past, present and future
Expert Rev Respir Med. 2024 Apr 22. doi: 10.1080/17476348.2024.2345684. Online ahead of print.ABSTRACTINTRODUCTION: Obstructive sleep apnea (OSA) is a widely prevalent condition with consequent multiple organ systems complications. There is consensus that OSA is associated with negative effects on pulmonary hemodynamics but whether it contributes to development of clinical pulmonary hypertension (PH) is unclear.AREAS COVERED: In this review we 1) highlight previous studies looking into the possible bidirectional association of OSA and PH, focusing on those that explore clinical prognostic implications, 2) explore potential...
Source: Expert Review of Respiratory Medicine - April 22, 2024 Category: Respiratory Medicine Authors: Jyotirmayee Lenka Raymond Foley Mark Metersky Adrian Salmon Source Type: research

Drug-induced interstitial lung disease: a narrative review of a clinical conundrum
Expert Rev Respir Med. 2024 Jan-Feb;18(1-2):23-39. doi: 10.1080/17476348.2024.2329612. Epub 2024 Mar 19.ABSTRACTINTRODUCTION: Drug-induced interstitial lung disease (DI-ILD) is increasing in incidence, due to the use of many new drugs across a broad range of cancers and chronic inflammatory diseases. The presentation and onset of DI-ILD are variable even for the same drug across different individuals. Clinical suspicion is essential for identifying these conditions, with timely drug cessation an important determinant of outcomes.AREAS COVERED: This review provides a comprehensive and up-to-date summary of epidemiology, ris...
Source: Expert Review of Respiratory Medicine - March 19, 2024 Category: Respiratory Medicine Authors: Megan Harrison Grace Kavanagh Tamera J Corte Lauren K Troy Source Type: research

Drug-induced interstitial lung disease: a narrative review of a clinical conundrum
Expert Rev Respir Med. 2024 Mar 19:1-17. doi: 10.1080/17476348.2024.2329612. Online ahead of print.ABSTRACTINTRODUCTION: Drug-induced interstitial lung disease (DI-ILD) is increasing in incidence, due to the use of many new drugs across a broad range of cancers and chronic inflammatory diseases. The presentation and onset of DI-ILD are variable even for the same drug across different individuals. Clinical suspicion is essential for identifying these conditions, with timely drug cessation an important determinant of outcomes.AREAS COVERED: This review provides a comprehensive and up-to-date summary of epidemiology, risk fac...
Source: Expert Review of Respiratory Medicine - March 19, 2024 Category: Respiratory Medicine Authors: Megan Harrison Grace Kavanagh Tamera J Corte Lauren K Troy Source Type: research